Clin2
NCT07187466Worth exploringNot yet recruiting

Treating urinary symptoms in Parkinson disease

Overactive BladderParkinson Disease

Treatments studied

Part of Brain & nervous system, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study tests whether a medication called mirabegron, a behavioral program, or both can improve urinary symptoms (like urgency and leakage) in people with Parkinson's disease. It may help you have better bladder control and daily comfort.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
146 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have Parkinson's disease and your doctor confirms it
  • You have bothersome urinary symptoms like sudden urges to pee, leaking, or needing to go often (score 7 or higher on a symptom questionnaire)
  • You are not on a catheter, have not had certain bladder surgeries, and have not had botox in your bladder in the last year
  • You do not have severe memory or thinking problems (dementia)
  • You are not on dialysis or have cancer treatment affecting your bladder

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05362292Recruiting· Phase 4
Treating bladder leakage to support mind and body health

This study tests medicines to reduce “urgency” urine leakage (when you suddenly feel you must go) and to see whether improving bladder control also helps overall mental and physical health. You may be eligible if you have had these symptoms for at least 3 months and can follow the study plan.

Palo Alto, California
NCT06662565Not yet recruiting
Pelvic floor training for overactive bladder in women

This trial tests a relaxation-based pelvic floor training program for women with overactive bladder and constipation. It may help improve bladder control and bowel function.

Cairo
NCT05997043Recruiting· Early Phase 1
Botulinum toxin for overactive bladder in Parkinson's disease

This trial tests if botulinum toxin A injections can help control overactive bladder symptoms in people with Parkinson's disease who haven't gotten enough relief from standard bladder medications. It aims to see if the treatment is safe and effective.

Guangzhou, Guangdong
NCT07627529Not yet recruiting· Phase 4
Safely Stopping Bladder Medications in Parkinson Disease

This study tests whether people with Parkinson disease can safely stop taking antimuscarinic medications (commonly used for overactive bladder) under medical supervision. The goal is to see if stopping these medications might help with thinking and memory problems that can be side effects.

Philadelphia, Pennsylvania
NCT07773532Not yet recruiting
Blood tests to predict bladder medication response in women

This trial tests whether simple blood tests can predict how well a woman with overactive bladder will respond to the medication mirabegron (also called Myrbetriq). If successful, doctors may be able to choose the right treatment earlier.

Istanbul, Bagcilar
NCT05874375Recruiting
Study for overactive bladder symptoms in men

This trial looks at a treatment for overactive bladder in adult men. If you qualify, you may be asked to follow study instructions and report symptom changes during treatment.

Maastricht

Hear when a new Overactive Bladder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.